Translational Development Acquisition Corp
NASDAQ:TDAC
Income Statement
Earnings Waterfall
Translational Development Acquisition Corp
Income Statement
Translational Development Acquisition Corp
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||
| Operating Expenses |
(0)
|
(1)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(0)
|
(1)
|
(1)
|
(1)
|
|
| Operating Income |
(0)
N/A
|
(1)
-177%
|
(1)
-40%
|
(1)
-20%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
0
|
2
|
4
|
6
|
|
| Pre-Tax Income |
(0)
N/A
|
1
N/A
|
3
+115%
|
5
+57%
|
|
| Net Income | |||||
| Tax Provision |
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
1
|
3
|
5
|
|
| Net Income (Common) |
(0)
N/A
|
1
N/A
|
3
+115%
|
5
+57%
|
|
| EPS (Diluted) |
0
N/A
|
0.06
N/A
|
0.14
+133%
|
0.22
+57%
|
|